Conjugative Metabolism of Drugs

Drug Metabolism in Drug Design and Development: Basic Concepts and Practice

Volumn , Issue , 2007, Pages 37-88

  Remmel, Rory ^a   Nagar, Swati ^b   Argikar, Upendra ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Hepatocyte sinusoidal and bile canalicular membrane; Liquid chromatography mass spectrometry; Reactive electrophilic metabolites formation

Indexed keywords

EID: 84881323217     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470191699.ch3     Document Type: Chapter

References (78)

1. Aksoy IA, Weinshilboum RM. Human thermolabile phenol sulfotransferase gene (STM): molecular cloning and structural characterization. Biochem Biophys Res Commun 1995;208(2):786-795.
2. Anderson R, Weinshilboum R. Phenolsulfotransferase in human tissue: radiochemical enzymatic assay and biochemical properties. Clin Chem Acta 1980;103:79-90.
3. Asai A, Miyazawa T. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sci 2000;67(23):2785-2793.
4. Bamber D, Fryer A. et al. Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colon cancer. Pharmacogenetics 2001;11:679-685.
5. Bartsch H. DNA adducts in human carcinogenesis: etiological relevance and structureactivity relationship. Mutat Res 1996;340(2-3):67-79.
6. Beckmann JD, Illig M. et al. Regulation of phenol sulfotransferase expression in cultured bovine bronchial epithelial cells by hydrocortisone. J Cell Physiol 1994;160(3):603-610.
7. Blanchard et al., 2004 Blanchard RL, Freimuth RR. et al. A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics 2004;14(3):199-211.
8. Board PG, Anders MW. Human glutathione transferase zeta. Methods Enzymol 2005;401:61-77.
9. Boogaard PJ, Mulder GJ, Nagelkerke JF. Isolated proximal tubular cells from rat kidney as an in vitro model for studies on nephrotoxicity. II. Alpha-methylglucose uptake as a sensitive parameter for mechanistic studies of acute toxicity by xenobiotics. Toxicol Appl Pharmacol 1989;101(1):144-157.
10. Bossuyt X, Blanckaert N. Carrier-mediated transport of intact UDP-glucuronic acid into the lumen of endoplasmic-reticulum-derived vesicles from rat liver. Biochem J 1994a;302(1):261-269.
11. Bossuyt X, Blanckaert N. Functional characterization of carrier-mediated transport of uridine diphosphate N-acetylgylucosamine across the endoplasmic reticulum membrane. Eur J Biochem 1994b;223(3):981-988.
12. Bossuyt X, Blanckaert N. Uridine diphosphoxylose enhances hepatic microsomal UDPglucuronosyltransferase activity by stimulating transport of UDP-glucuronic acid across the endoplasmic reticulum membrane. Biochem J 1996;315(1):189-193.
13. Bredschneider M, Klein K, Murdter TE. et al. Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugation. Clin Pharmacol Ther 2002;71(6):479-487.
14. Brennan MD, and Condra J. Transmission disequilibrium suggests a role for the sulfotransferase-4A1 gene in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2005;139(1):69-72.
15. Cawley AT,Kazlauskas R. et al. Determination of urinary steroid sulfate metabolites using ion paired extraction. JChromatogrBAnalyt TechnolBiomedLifeSci 2005;825(1):1-10.
16. Chen H, Wang H. et al. Liquid chromatography-tandem mass spectrometry analysis of anisodamine and its phase I and II metabolites in rat urine. J Chromatogr B Analyt Technol Biomed Life Sci 2005;824(1-2):21-29.
17. Chou DKH, Flores S, Jungalwala FB. J Biol Chem 1991;266:17941-17949.
18. Coles BF, Kadlubar FF. Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol 2005;401:9-42.
19. Coles BF, Morel F, Rauch C. et al. Effect of polymorphism in the human glutathione Stransferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 2001;11(8):663-669.
20. Coughtrie M. Sulfation through the looking glass - recent advances in sulfotransferase research for the curious. Pharmacogenomics J 2002;2:297-308.
21. Duanmu Z, Dunbar J. et al. Induction of rat hepatic aryl sulfotransferase (SULT1A1) gene expression by triamcinolone acetonide: impact on minoxidil-mediated hypotension. Toxicol Appl Pharmacol 2000;164(3):312-320.
22. Duanmu Z, Locke D. et al. Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metab Dispos 2002;30(9):997-1004.
23. Foldes A, Meek JL. Rat brain phenolsulfotransferase: partial purification and some properties. Biochim Biophys Acta 1973;327(2):365-374.
24. Gamage N, Barnett A. et al. Human sulfotransferases and their role in chemical metabolism. Toxicol Sci 2005.
25. Garte S, Gaspari L, Alexandrie AK. et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001;10(12): 1239-1248.
26. Glatt H. Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 2000;129(1-2):141-170.
27. Goldberg ME, Cantillo J, Gratz I. et al. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers. Anesth Analg 1999;88(2):437-445.
28. Goto S, Kamada K, Soh Y, Ihara Y, Kondo T. Significance of nuclear glutathione Stransferase pi in resistance to anti-cancer drugs. Jpn J Cancer Res 2002;93(9):1047-1056.
29. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88.
30. Her C, Raftogianis R. et al. Human phenol sulfotransferase STP2 gene: molecular cloning, structural characterization, and chromosomal localization. Genomics 1996;33(3):409-420.
31. Itoh K, Tong KI, Yamamoto M. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 15 2004;36(10):1208-1213.
32. Jowsey IR, Thomson AM, Flanagan JU. et al. Mammalian class Sigma glutathione S-transferases: catalytic properties and tissue-specific expression of human and rat GSH-dependent prostaglandin D2 synthases. Biochem J 2001;359(Pt 3):507-516.
33. Kulp KS, Knize MG. et al. Identification of urine metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans. Carcinogenesis 2000;21(11):2065-2072.
34. Liu L, Klaassen CD. Regulation of hepatic sulfotransferases by steroidal chemicals in rats. Drug Metab Dispos 1996;24(8):854-858.
35. Maglich JM, Parks DJ. et al. Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem 2003;278(19):17277-17283.
36. Mannervik B, Board PG, Hayes JD, Listowsky I, Pearson WR. Nomenclature for mammalian soluble glutathione transferases. Methods Enzymol 2005;401:1-8.
37. Marchetti F, De Santi C. et al. Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine. Xenobiotica 2001;31(12):841-847.
38. Matsuno K, Kubota T, Matsukura Y, Ishikawa H, Iga T. Genetic analysis of glutathione S-transferase A1 and T1 polymorphisms in a Japanese population. Clin Chem Lab Med 2004;42(5):560-562.
39. McWalter GK, Higgins LG, McLellan LI. et al. Transcription factor Nrf2 is essential for induction of NAD(P)H:quinone oxidoreductase 1, glutathione S-transferases, and glutamate cysteine ligase by broccoli seeds and isothiocyanates. J Nutr 2004;134(12 Suppl):3499S-3506S.
40. Morgenstern R. Microsomal glutathione transferase 1. Methods Enzymol 2005;401:136-146.
41. Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 2004;10(11):549-557.
42. Mulder GJ, Scholtens E. Phenol sulphotransferase and uridine diphosphate glucuronyltransferase from rat liver in vivo and vitro. 2,6-Dichloro-4-nitrophenol as selective inhibitor of sulphation. Biochem J 1977;165(3):553-559.
43. Nagar S, Walther S. et al. Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation. Mol Pharmacol 2006;69(6):2084-2092.
44. Nakajima M, Yamato S. et al. Determination of dehydroepiandrosterone sulphate in biological samples by liquid chromatography/atmospheric pressure chemical ionization-mass spectrometry using [7,7,16,16-2H4]-dehydroepiandrosterone sulphate as an internal standard. Biomed Chromatogr 1998;12(4):211-216.
45. Ntais C, Polycarpou A, Ioannidis JP. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2005;14(1):176-181.
46. Ogilvie BW, Zhang D. et al. Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: implications for drug-drug interactions. Drug Metab Dispos 2006;34(1):191-197.
47. Pacifici GM, Coughtrie MWH. Human Cytosolic Sulfotransferases. Boca Raton FL:CRC Press; 2005.
48. Park EY, Cho IJ, Kim SG. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferatoractivated receptor-gamma and retinoid X receptor heterodimer. Cancer Res 152004;64(10):3701-3713.
49. Pemble SE, Wardle AF, Taylor JB. Glutathione S-transferase class Kappa:characterization by the cloning of rat mitochondrial GST and identification of a human homologue. Biochem J Nov 1 1996;319(Pt 3):749-754.
50. Peters U, Preisler-Adams S, Hebeisen A. et al. Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Anticancer Drugs 2000;11(8):639-643.
51. Piirila P, Wikman H, Luukkonen R. et al. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics 2001;11(5):437-445.
52. Raftogianis RB, Her C. et al. Human phenol sulfotransferase pharmacogenetics: STP1 gene cloning and structural characterization. Pharmacogenetics 1996;6(6):473-487.
53. Raftogianis RB, Wood TC. et al. Human phenol sulfotransferases SULT1A2 and SULT1A1:genetic polymorphisms, allozyme properties, and human liver genotypephenotype correlations. Biochem Pharmacol 1999;58(4):605-616.
54. Risch A, Wikman H, Thiel S. et al. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics 2001;11(9):757-764.
55. Robbins PW, Lipmann F. Isolation and identification of active sulfate. J Biol Chem 1957;229(2):837-851.
56. Runge-Morris M, Rose K. et al. Regulation of rat hepatic sulfotransferase gene expression by glucocorticoid hormones. Drug Metab Dispos 1996;24(10):1095-1101.
57. Runge-Morris M, Wu W. et al. Regulation of rat hepatic hydroxysteroid sulfotransferase (SULT2-40/41) gene expression by glucocorticoids: evidence for a dual mechanism of transcriptional control. Mol Pharmacol 1999;56(6):1198-1206.
58. Schuur AG, Legger FF. et al. In vitro inhibition of thyroid hormone sulfation by hydroxylated metabolites of halogenated aromatic hydrocarbons. Chem Res Toxicol 1998;11(9):1075-1081.
59. Schramm VL, McCluskey R, Emig FA, Litwack G. Kinetic studies and active sitebinding properties of glutathione S-transferase using spin-labeled glutathione, a product analogue. J Biol Chem 251984;259(2):714-722.
60. Seah VM, Wong KP. 2,6-Dichloro-4-nitrophenol (DCNP), an alternate-substrate inhibitor of phenolsulfotransferase. Biochem Pharmacol 1994;47(10):1743-1749.
61. Shima N, Tsutsumi H. et al. Direct determination of glucuronide and sulfate of p-hydroxymethamphetamine in methamphetamine users' urine. J Chromatogr B Analyt Technol Biomed Life Sci 2005.
62. Sohlenius-Sternbeck AK, Schmidt S. Impaired glutathione-conjugating capacity by cryopreserved human and rat hepatocytes. Xenobiotica 2005;35(7):727-736.
63. Sonoda J, Xie W. et al. Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci U S A 2002;99(21):13801-13806.
64. Sorensen M, Autrup H, Tjonneland A, Overvad K, Raaschou-Nielsen O. Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer. Int J Cancer 102004;110(2):219-224.
65. Soucy NV, Parkinson HD. et al. Kinetics of genistein and its conjugated metabolites in pregnant sprague-dawley rats following single and repeated genistein administration. Toxicol Sci 2005.
66. Stern ST, Bruno MK, Hennig GE, Horton RA, Roberts JC, Cohen SD. Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity in CD-1 mice: I. Enhancement of acetaminophen nephrotoxicity by acetaminophen-cysteine. Toxicol Appl Pharmacol 152005;202(2):151-159.
67. Tetlow N, Liu D, Board P. Polymorphism of human Alpha class glutathione transferases. Pharmacogenetics 2001;11(7):609-617.
68. Tong Z, Board PG, Anders MW. Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other alpha-haloacids. Chem Res Toxicol 1998;11(11):1332-1338.
69. Trapnell CB, Klecker RW. et al. Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid. Antimicrob Agents Chemother 1998;42(7):1592-1596.
70. van der Woude H, Boersma MG. et al. Identification of 14 quercetin phase II monoand mixed conjugates and their formation by rat and human phase II in vitro model systems. Chem Res Toxicol 2004;17(11):1520-1530.
71. Varin L, Barron D. et al. Enzymatic assay for flavonoid sulfotransferase. Anal Biochem 1987;161(1):176-180.
72. Vietri M, Pietrabissa A. et al. Differential inhibition of hepatic and duodenal sulfation of (-)-salbutamol and minoxidil by mefenamic acid. Eur J Clin Pharmacol 2000;56(6-7):477-479.
73. Vietri M, Vaglini F. et al. Sulfation of R(-)-apomorphine in the human liver and duodenum, and its inhibition by mefenamic acid, salicylic acid and quercetin. Xenobiotica 2002;32(7):587-594.
74. Warholm M, Guthenberg C, Mannervik B. Molecular and catalytic properties of glutathione transferase mu from human liver: an enzyme efficiently conjugating epoxides. Biochemistry 191983;22(15):3610-3617.
75. Weinshilboum RM, Otterness DM. et al. Sulfation and sulfotransferases 1:sulfotransferase molecular biology: cDNAs and genes. FASEB J 1997;11(1):3-14.
76. Zhang D, Zhao W, Roongta V, Mitroka J, Klunk L, Zhu M. Amide N-glucuronidation of maxipost catalyzed by UGP-glucuronosyltransferase 2B7 in humans. Drug Metab Dispos 2004;32:545-551.
77. Zhang D, Chando TJ, Everett DW, Patten CJ, Dehal SS, Humphreys WG. In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other protease inhibitors and the relationship of this properties to in vivo bilirubin glucuronidation. Drug Metab Dispos 2005;33:1729-1739.
78. Zheng W, Xie D. et al. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:89-94.